The intersection of AI and healthcare represents a frontier of exciting possibilities. Yet, as the FDA’s recent incident illustrates, vigilance is key. It serves as a reminder that technology, no matter how advanced, is a tool – and like any tool, it requires careful handling.
As we proceed into this new era, collaboration and communication between tech developers, healthcare providers, and regulatory bodies will be essential. By ensuring AI serves as a helper, not a master, we can harness its full potential, bolstering public health and safeguarding trust along the way.
